3,872
Views
36
CrossRef citations to date
0
Altmetric
Research Article

Triphala herbal extract suppresses inflammatory responses in LPS-stimulated RAW 264.7 macrophages and adjuvant-induced arthritic rats via inhibition of NF-κB pathway

&
Pages 509-525 | Received 03 Aug 2015, Accepted 21 Dec 2015, Published online: 20 Jul 2016

References

  • Ahmad R, Rasheed Z, Ahsan H. 2009. Biochemical and cellular toxicology of peroxy-nitrate implications in cell death and autoimmune phenomenon. Immunopharmacol Immunotoxicol. 31:388–396.
  • Ahn CB, Jung WK, Park SJ, Kim YT, Kim WS, Je JY. 2015. Gallic acid-γ-chitosan modulates inflammatory responses in LPS-stimulated RAW 264.7 cells via NF-κB, AP-1, and MAPK pathways Inflammation. [Epub ahead of print]. doi: 10.1007/s10753-015-0258-2.
  • Ahn SC, Kim GY, Kim JH, Baik SW, Han MK, Lee HJ, Moon DO, Lee CM, Kang JH, Kim BH. 2004. Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-κB. Biochem Biophys Res Commun. 313:148–55.
  • Biber J, Stieger B, Haase W, Murer H. 1981. A high yield, preparation of rat kidney brush-border membranes, different behaviors of lysosomal markers. Biochim Biophys Acta. 647:169–176.
  • Biswas SK, Lewis CE. 2010. NF-κB as a central regulator of macrophage function in tumors. J Leukocyte Biol. 88:877–884.
  • Byun EB, Choi HG, Sung NY, Byun EH. 2012. Green tea polyphenol epigallocatechin-3-gallate inhibits TLR4 signaling through the 67-kDa laminin receptor on LPS-stimulated dendritic cells. Biochem Biophys Res Commun. 426:480–485.
  • Byun EH, Omura T, Yamada K, Tachibana H. 2011. Green tea polyphenol epigallocate-chin-3-gallate inhibits TLR2 signaling induced by peptidoglycan through the polyphenol sensing molecule 67-kDa laminin receptor. FEBS Lett. 9:814–820.
  • Chen CY, Chen KC, Yang TY, Liu HC, Hsu SL. 2013. Gallic acid induces a reactive oxygen species-provoked c-jun NH2-terminal kinase-dependent apoptosis in lung fibroblasts. Evid-Based Complement Alt Med. 2013:1–12.
  • Cheng HY, Lin TC, Yu KH, Yang CM, Lin CC. 2003. Anti-oxidant and free radical scavenging activities of Terminalia chebula. Biol Pharm Bull. 26:1331–1335.
  • Cho ML, Kang JW, Moon YM, Nam HJ, Jhun JY, Heo SB, Jin HT, Min SY, Ju JH, Park KS, et al. 2006. STAT3 and NF- κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J Immunol. 176:5652–5661.
  • Choi KC, Lee YH, Jung MG, Kwon SH, Kim MJ, Jun WJ, Lee J, Lee JM, Yoon HG. 2009. Gallic acid suppresses lipopolysaccharide-induced NF- κB signaling by preventing RelA acetylation in A549 lung cancer cells. Mol Cancer Res. 7:2011–2021.
  • Choudhari AS, Raina P, Deshpande MM, Wali AG, Zanwar A, Bodhankar SL, Kaul-Ghanekar R. 2013. Evaluating the anti-inflammatory potential of Tectaria cicutaria L. rhizome extract in vitro as well as in vivo. J Ethnopharmacol. 150:215–222.
  • El-Mekkawy S, Meselhy MR, Kusumoto I, Kadota TS, Hattori M, Namba T. 1995. Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem Pharm Bull. 43:641–648.
  • Geusens P. 2012. The role of RANK ligand/osteoprotegerin in rheumatoid arthritis. Ther Adv Musculoskel Dis. 4:225–233.
  • Grivennikov SI, Greten FR, Karin M. 2010. Immunity, inflammation, and cancer. Cell. 140:883–899.
  • Hari Kumar KB, Sabu MC, Lima PS, Kuttan R. 2004. Modulation of hematopoetic system and anti-oxidant enzymes by Emblica officinalis Gaertn and its protective role against γ-radiation-induced damage in mice. J Radiation Res (Tokyo). 45:549–555.
  • Ho HH, Chang CS, Ho WC, Liao SY, Wu CH, Wang CJ. 2010. Anti-metastasis effects of gallic acid on gastric cancer cells involve inhibition of NF-κB activity and down-regulation of PI3K/AKT/small GTPase signals. Food Chem Toxicol. 48:2508–2516.
  • Hwang JM, Yu JY, Jang YO, Kim BT, Hwang KJ, Jeon YM, Lee JC. 2010. A phenolic acid phenethyl urea compound inhibits lipopolysaccharide-induced production of nitric oxide and pro-inflammatory cytokines in cell culture. Intl Immunopharmacol. 10:526–532.
  • Jagetia GC, Baliga MS, Malagi KJ, Kamath SM. 2002. Evaluation of the radioprotective effect of triphala in mice exposed to γ-radiation. Phytomedicine. 9:99–108.
  • Jaijoy K, Soonthornchareonnon N, Panthong A, Sireeratawong S. 2010. Anti-inflammatory and analgesic activities of the water extract from the fruit of Phyllanthus emblica Linn. Int J Appl Res Nat Prod. 3:28–35.
  • Kalaiselvan S, Rasool M. 2015b. Triphala exhibits anti-arthritic effect by ameliorating bone and cartilage degradation in adjuvant-induced arthritis rats. Immunol Invest. 44:411–426.
  • Kalaiselvan S, Rasool MK. 2015a. The anti-inflammatory effect of triphala in adjuvant-induced arthritis in rats. Pharm Biol. 53:51–60.
  • Karlsson S, Nanberg E, Fjaeraa C, Wijkander J. 2010. Ellagic acid inhibits LPS-induced expression of enzymes involved in the synthesis of PGE2 in human monocytes. Br J Nutr. 103:1109–1119.
  • Karuppagounder V, Arumugam S, Thandavarayan RA, Pitchaimani V, Sreedhar R, Afrin R, Harima M, Suzuki H, Nomoto M, Miyashita S, et al. 2015. Tannic acid modulates NF-κB signaling pathway and skin inflammation in NC/Nga mice through PPARγ expression. Cytokine. 76:206–213.
  • Kaur S, Arora S, Kaur K, Kumar S. 2002. The in vitro anti-mutagenic activity of triphala – an Indian herbal drug. Food Chem Toxicol. 40:527–534.
  • Kaur S, Michael H, Arora S. 2005. The in vitro cytotoxic and apoptotic activity of triphala – an Indian herbal drug. J Ethnopharmacol. 97:15–20.
  • King J. 1965. The hydrolases-acid and alkaline phosphatases In: Van D, editor. Practical clinical enzymology. London: Van Nostrand Company Ltd, p. 191–208.
  • Kumar MS, Kirubanandan S, Sripriya R, Sehgal PK. 2010. Triphala-incorporated collagen sponge – a smart biomaterial for infected dermal wound healing. J Surg Res. 158:162–170.
  • Lee MY, Park BY, Kwon OK, Yuk JE, Oh SR, Kim HS, Lee HK, Ahn KS. 2009. Anti-inflammatory activity of (-) aptosimon isolated from Daphne genkwa in RAW 264.7 cells. Intl Immunopharmacol. 9:878–885.
  • Lee SI, Hyun PM, Kim SH, Kim KS, Lee SK, Kim BS, Maeng PJ, Lim JS. 2005a. Suppression of the onset and progression of collagen induced arthritis by chebulagic acid screened from a natural product library. Arthritis Rheum. 52:345–353.
  • Lee YS, Han OK, Park CW, Yang CH, Jeon TW, Yoo WK, Kim SH, Kim HJ. 2005b. Pro-inflammatory cytokine gene expression and nitric oxide regulation of aqueous extracted Astragali radix in RAW 264.7 macrophage cells. J Ethnopharmacol. 100:289–294.
  • Li F, Nitteranon V, Tang X, Liang J, Zhang G, Parkin KL, Hu Q. 2012. In vitro anti-oxidant and anti-inflammatory activities of 1-dehydro-[6]-gingerdione, 6-shogaol, 6-dehydroshogaol and hexahydrocurcumin. Food Chem. 135:332–337.
  • Liu Y, Bao L, Xuan L, Song B, Lin L, Han H. 2015. Chebulagic acid inhibits the LPS-induced expression of NF-κB and IL-1β in endothelial cells by suppressing MAPK activation. Exp Ther Med. 10:263–268.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265–275.
  • Maruhn D. 1976. Rapid colorimetric assay of β-galactosidase and N-acetyl-β-glucosaminidase in human urine. Clin Chim Acta 73:453–461.
  • Na HJ, Lee G, Oh HY, Jeon KS, Kwon HJ, Ha KS, Lee H, Kwon YG, Kim YM. 2006. 4-O-Methylgallic acid suppresses inflammation-associated gene expression by inhibition of redox-based NF-κB activation. Intl Immunopharmacol. 6:1597–1608.
  • Nampoothiri SV, Prathapan A, Cherian OL, Raghu KG, Venugopalan VV, Sundaresan A. 2011. In vitro anti-oxidant and inhibitory potential of Terminalia bellerica and Emblica officinalis fruits against LDL oxidation and key enzymes linked to Type 2 diabetes. Food Chem Toxicol. 49:125–131.
  • Pawar V, Lahorkar P, Anantha Narayana DB. 2009. Development of RP-HPLC method for analysis of triphala curna and its applicability to test variations in triphala curna preparations. Indian J Pharm Sci. 71:382–386.
  • Pragasam SJ, Rasool M. 2013. Dietary component p-coumaric acid suppresses mono sodium urate crystal-induced inflammation in rats. Inflamm Res. 62:489–498.
  • Rasool M, Varalakshmi P. 2006. Suppressive effect of Withania somnifera root powder on experimental gouty arthritis: an in vivo and in vitro study. Chem Biol Interact. 164:174–180.
  • Rasool M, Sabina EP. 2007. Anti-inflammatory effect of the Indian Ayurvedic herbal formulation triphala on adjuvant-induced arthritis in mice. Phytother Res. 21:889–894.
  • Reddy DB, Reddanna P. 2009. Chebulagic acid (CA) attenuates LPS-induced inflammation by suppressing NF-κB and MAPK activation in RAW 264.7 macrophages. Biochem Biophys Res Commun. 381:112–117.
  • Rosenblit PD, Metzyer RP, Wick AN. 1974. Effect of streptozotocin diabetes on acid phosphatase and selected glycosidase activities of serum and various rat organs. Proc Soc Exp Biol Med. 14:244–248.
  • Rosillo MA, Sánchez-Hidalgo M, Cárdeno A, Aparicio-Soto M, Sánchez-Fidalgo S, Villegas I, de la Lastra CA. 2012. Dietary supple-mentation of ellagic acid-enriched pomegranate extract attenuates chronic colonic inflamma-tion in rats. Pharmacol Res. 66:235–242.
  • Ryter SW, Otterbein LE, Morse D, Choi AM. 2002. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem. 234:249–263.
  • Sabina EP, Rasool M. 2008. An in vivo and in vitro potential of Indian ayurvedic herbal formulation triphala on experimental gout arthritis in mice. Vasc Pharmacol. 48:14–20.
  • Sabina EP, Rasool MK, Mathew L. 2009. In vivo and in vitro immunomodulatory effects of Indian Ayurvedic herbal formulation triphala on experimentally-induced inflammation. Pharmacologyonline. 2:840–849.
  • Sabu MC, Kuttan R. 2002. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 81:155–160.
  • Sandhyaa T, Lathikaa KM, Pandeyb BN, Mishraa KP. 2006. Potential of traditional Ayurvedic formulation, triphala, as a novel anti-cancer drug. Cancer Lett. 231:206–214.
  • Salvemini D, Kim SF, Mollace V. 2013. Reciprocal regulation of the nitric oxide and cyclo-oxygenase pathway in pathophysiology: relevance and clinical implications. Am J Physiol. 304:R473–R487.
  • Singh DP, Govindarajan R, Rawat AK. 2008. High-performance liquid chromatography as a tool for the chemical standardisation of triphala – an Ayurvedic formulation. Phytochem Anal. 19:164–168.
  • Sulthana F, Rasool M. 2015. A novel therapeutic approach targeting rheumatoid arthritis by combined administration of morin, a dietary flavanol and non-steroidal anti-inflammatory drug indomethacin with reference to pro-inflammatory cytokines, inflammatory enzymes, RANKL and transcription factors. Chem-Biol Interactions. 230:58–70.
  • Takagi N, Sanashiro T. 1996. Health foods containing anti-oxidative and anti-allergy food materials. Japan Kokai Tokkyo Hoho. 70:1000.
  • Ulivi V, Giannoni P, Gentili C, Cancedda R, Descalzi F. 2008. p38/NF-κB-dependent expression of COX-2 during differentiation and inflammatory response of chondrocytes. J Cell Biochem. 104:1393–1406.
  • Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, Figdor CG. 2003. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev. 55:551–571.
  • Wang QS, Cui YL, Wang YF, Chi W. 2011. Effects of compounds from Bi-Qi capsule on the expression of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 macrophages. J Ethnopharmacol. 136:480–487.
  • Willis D, Moore AR, Frederick R, Willoughby DA. 1996. Heme oxygenase: a novel target for the modulation of inflammatory response. Nat Med. 2:87–93.
  • Yu YM, Wang ZH, Liu CH, Chen CS. 2007. Ellagic acid inhibits IL-1β-induced cell adhesion molecule expression in human umbilical vein endothelial cells. Br J Nutr. 97:692–698.
  • Zhao L, Zhang SL, Tao JY, Pang R, Jin F, Guo YJ, Dong JH, Ye P, Zhao HY, Zheng GH. 2008. Preliminary exploration on anti-inflammatory mechanism of corilagin (β1-ogalloyl- 3, 6-(R)-hexahydroxydiphenoyl-D-glucose) in vitro. Intl Immunopharmacol. 8:1059–1064.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.